Sign In
Buy BNTC
$11.71
-0.150 (-1.26%)
At Close: Jul 31, 2026
Benitec Biopharma Inc. Announces Proposed Public Offering
04:43pm, Wednesday, 05'th Nov 2025
HAYWARD, Calif., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (Nasdaq: BNTC) (“Benitec” or the “Company”), a clinical-stage, gene therapy-focused, biotechnology company developing
HAYWARD, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (NASDAQ: BNTC) (“Benitec” or “Company”), a clinical-stage, gene therapy-focused, biotechnology company developing nove
Benitec Biopharma to Provide Phase 1b/2a Clinical Study Update for BB-301 in Oculopharyngeal Muscular Dystrophy
07:00pm, Sunday, 02'nd Nov 2025
Investor webcast to be held on Monday November 3, 2025 at 8:00 am EST Investor webcast to be held on Monday November 3, 2025 at 8:00 am EST
Benitec Biopharma Limited (NASDAQ:BNTC) Given Consensus Rating of “Moderate Buy” by Analysts
01:31am, Sunday, 26'th Oct 2025
Benitec Biopharma Limited (NASDAQ: BNTC - Get Free Report) has been assigned an average rating of "Moderate Buy" from the nine analysts that are presently covering the company, MarketBeat.com reports.
Benitec Biopharma Releases Full Year 2025 Financial Results and Provides Operational Update
04:05pm, Monday, 22'nd Sep 2025
Interim Clinical Study Results for Cohort 1 of the BB-301 Phase 1b/2a Treatment Study Anticipated in Q4 2025 Enrollment of the First Subject into Cohort 2 of the BB-301 Phase 1b/2a Treatment Study Exp
Benitec Biopharma (BNTC) is on the Move, Here's Why the Trend Could be Sustainable
09:51am, Monday, 16'th Jun 2025
If you are looking for stocks that are well positioned to maintain their recent uptrend, Benitec Biopharma (BNTC) could be a great choice. It is one of the several stocks that passed through our "Rece
Wall Street Analysts See a 65.98% Upside in Benitec Biopharma (BNTC): Can the Stock Really Move This High?
11:02am, Thursday, 05'th Jun 2025
The average of price targets set by Wall Street analysts indicates a potential upside of 66% in Benitec Biopharma (BNTC). While the effectiveness of this highly sought-after metric is questionable, th
Is Benitec Biopharma (BNTC) Outperforming Other Medical Stocks This Year?
10:46am, Wednesday, 04'th Jun 2025
Here is how Benitec Biopharma Limited (BNTC) and Delcath Systems, Inc. (DCTH) have performed compared to their sector so far this year.
Recent Price Trend in Benitec Biopharma (BNTC) is Your Friend, Here's Why
09:50am, Thursday, 29'th May 2025
Benitec Biopharma (BNTC) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
Wall Street Analysts Think Benitec Biopharma (BNTC) Could Surge 83.91%: Read This Before Placing a Bet
11:01am, Tuesday, 20'th May 2025
The mean of analysts' price targets for Benitec Biopharma (BNTC) points to an 83.9% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement amo
Are Medical Stocks Lagging Benitec Biopharma (BNTC) This Year?
10:46am, Monday, 19'th May 2025
Here is how Benitec Biopharma Limited (BNTC) and Concentra Group (CON) have performed compared to their sector so far this year.
Benitec Biopharma (BNTC) Is a Great Choice for 'Trend' Investors, Here's Why
09:51am, Monday, 05'th May 2025
Benitec Biopharma (BNTC) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
Is Benitec Biopharma (BNTC) Stock Outpacing Its Medical Peers This Year?
10:46am, Friday, 02'nd May 2025
Here is how Benitec Biopharma Limited (BNTC) and Concentra Group (CON) have performed compared to their sector so far this year.
Wall Street Analysts Believe Benitec Biopharma (BNTC) Could Rally 84.96%: Here's is How to Trade
10:55am, Friday, 25'th Apr 2025
The consensus price target hints at an 85% upside potential for Benitec Biopharma (BNTC). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings
What Makes Benitec Biopharma (BNTC) a New Buy Stock
01:00pm, Wednesday, 23'rd Apr 2025
Benitec Biopharma (BNTC) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
